결핵 진료지침

### 참고문헌

1.  Korea Centers for Disease Control & Prevention. 2010 결핵관리지침; 2010.
2.  Korea Disease Control and Prevention Agency. Auunual report on the notified tuberculosis in Korea, 2022. 2023.
3.  Yoon HJ, Song YG, Park WI, Choi JP, Chang KH, Kim JM. Clinical manifestations and diagnosis of extrapulmonary tuberculosis. Yonsei Med J 2004;45:453-61.
4.  Long MD, Ellis E. Canadian tuberculosis standards. 6th ed. Minister of Health; 2007.
5.  Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician 2005;72: 1761-8.
6.  Fan L, Chen Z, Hao XH, Hu ZY, Xiao HP. Interferon-gamma releasing assays for the diagnosis of extrapulmonary tuberculosis: a systemic review and meta-analysis. FEMS Immunol Med Microbiol 2012;65:456-66.
7.  Cho OH, Park KH, Kim SM, et al. Diagnostic performance of T-SPOT.TB for extrapulmonary tuberculosis according to the site of infection. J Infect 2011;63:362-9.
8.  Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012;40:442-7.
9.  Gong X, He Y, Zhou K, Hua Y, Li Y. Efficacy of Xpert in tuberculosis diagnosis based on various specimens: a systemic review and meta-analysis. Front Cell Infect Microbiol 2023; 13:1149741
10. Kim YW, Kwak N, Seong MW, et al. Accuracy of the Xpert MTB/RIF assay for the diagnosis of extra-pulmonary tuberculosis in South Korea. Int J Tuberc Lung Dis 2015;19:81-6.
11. Choi OH, Park KH, Kim T, Song EH, Jang EY, Lee EJ, et al. Paradoxical responses in non-HIVinfected patients with peripheral lymph node tuberculosis. J Infect 2009;59:56-61.
12. Peto HM, Pratt RH, Harrington TA, et al. Epidemiology of extrapulmonary

<PAGE>179 VI. 폐외 결핵